Chemical Compound

Biotin-DEVD-CHO

CAS Registry Number 178603-73-1
Back to search Request a Quote
Biotin-DEVD-CHO chemical structure
Primary Record

Biotin-DEVD-CHO

In stock
7,683 g
Purity
99.5 %
CAS
178603-73-1

Compound Identifiers & Properties

CAS
178603-73-1
PubChem CID
644346
SMILES
CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCC[C@H]1[C@@H]2[C@H](CS1)NC(=O)N2
Canonical SMILES
CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(=O)N[C@H](C=O)CC(=O)O

Names & Synonyms

  • Biotin-DEVD-CHO
  • Biotinyl-DEVD-CHO
  • biotinyl-devd-aldehyde
  • 178603-73-1
  • biotin-asp-glu-val-asp-cho
  • AC1LD91X
  • Biotinyl-Asp-Glu-Val-Asp-CHO
  • Biotinyl-Asp-Glu-Val-Asp-al
  • Biotinyl-Asp-Glu-Val-Asp-aldehyde (pseudo acid)
  • SCHEMBL2037323
  • biotinyl-asp-glu-val-asp-aldehyde
  • DTXSID10349376
  • Caspase-3 Inhibitor I, Biotin Conjugate
  • CID644346
  • biotinyl-asp-glu-val-asp-h (aldehyde)
  • ZINC150341112
  • CID 644346
  • CPP32/Apopain Inhibitor, Biotin Conjugate
  • AN-30686
  • DA-71526
  • FB111057
  • J1.800.125J
  • 603B731
  • (4S)-4-[[(2S)-2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-carboxypropanoyl]amino]-5-[[(2S)-1-[[(2S)-1-carboxy-3-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid
  • L-valinamide, N-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-
  • (4S)-4-[(2S)-2-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-3-carboxypropanamido]-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid
  • (4S)-4-[(2S)-2-{5-[(3AS,4S,6AR)-2-OXO-HEXAHYDROTHIENO[3,4-D]IMIDAZOL-4-YL]PENTANAMIDO}-3-CARBOXYPROPANAMIDO]-4-{[(1S)-1-{[(2S)-1-CARBOXY-3-OXOPROPAN-2-YL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}BUTANOIC ACID
  • (4S)-4-[[(2S)-2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-carboxy-propanoyl]amino]-5-[[(1S)-1-[[(1S)-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]amino]-5-oxo-pentanoic acid
  • (4S)-4-[[(2S)-2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-4-hydroxy-4-oxobutanoyl]amino]-5-[[(2S)-1-[[(2S)-4-hydroxy-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid
  • (S)-3-Formyl-3-[[N-[5-[(3aS,6abeta)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4alpha-yl]pentanoyl]-L-Asp-L-Glu-L-Val-]amino]propanoic acid
  • L-Valinamide, N-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-alpha-aspartyl-L-alpha-glutamyl-N-(2-carboxy-1-formylethyl)-, [1[3aS-(3aalpha,4beta,6aalpha)],3(S)]-
  • L-Valinamide, N-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]- (9CI)
  • N-{5-[(3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}-L-alpha-aspartyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-valinamide